Journal of Cellular & Molecular Anesthesia

ISSN: 2538-2462

April 2016
Vol. 1 No. 2 (2016)

Dexmedetomidine Mechanism of Action: an update

Journal of Cellular & Molecular Anesthesia, Vol. 1 No. 2 (2016), , Page 91-94
https://doi.org/10.22037/jcma.v1i2.11398

Abstract

Dexmedetomidine (PRECEDEX) is an imidazole derivative that is a highly selective a2 receptor agonist. Activation of the a2 adrenergic receptors by dexmedetomidine leads to both sedation and analgesia; with negligible respiratory and cardiovascular side effects. The drug is likely to be increasingly used for sedation and as an anesthetic adjunct.
Keywords:
  • Dexmedetomidine
  • neuroprotection
  • reperfusion injury

How to Cite

1.
Salarian S, Taherkhanchi B, Dabbagh A, Darban M, Bagheri B. Dexmedetomidine Mechanism of Action: an update. J Cell Mol Anesth [Internet]. 2016Mar.16 [cited 2022Jul.7];1(2):91-4. Available from: https://journals.sbmu.ac.ir/jcma/article/view/11398

References

Purdon PL, Pierce ET, Mukamel EA, Prerau MJ, Walsh JL, Wong KF, Salazar-Gomez AF, Harrell PG, Sampson AL, Cimenser A, Ching S, Kopell NJ, Tavares-Stoeckel C, Habeeb K, Merhar R, Brown EN. 2013. Electroencephalogram signatures of loss and recovery of consciousness from propofol. Proceedings of the National Academy of Sciences of the United States of America 110:E1142-1151.

Purdon PL, Sampson A, Pavone KJ, Brown EN. 2015. Clinical Electroencephalography for Anesthesiologists: Part I: Background and Basic Signatures. Anesthesiology 123:937-960.

  • Abstract Viewed: 762 times
  • PDF Downloaded: 658 times

Download Statastics

Open Journal Systems
Keywords
Current Issue